WD
OSIP108 increased not only viability of Cu-treated CHO cells transgenically expressing ATP7B and the common WD-causing mutant ATP7B(H1069Q), but also viability of Cu-treated human glioblastoma U87 cells.
OSIP108 increased not only viability of Cu-treated CHO cells transgenically expressing <span class="gene" id="25134866-4-87-92">ATP7B</span> and the common <span class="disease" id="25134866-4-108-110">WD</span>-causing mutant <span class="gene" id="25134866-4-126-131">ATP7B</span>(H1069Q), but also viability of Cu-treated human glioblastoma U87 cells.